CoDa raises funds for wound gel clinical trial

04/20/2011 | San Diego Union-Tribune

CoDa Therapeutics announced that it has secured $19.2 million for a Phase II study of its topical gel Nexagon, which reduces protein production to encourage wound healing. In a previous midstage trial of the gel involving patients with venous leg ulcers, about 33% of participants' wounds were healed after four weeks.

View Full Article in:

San Diego Union-Tribune

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX